About CabApp
CabApp is a Healthcare company based in Vantaa (Finland) founded in 2019, and was acquired by MyXLine in February 2024. It operates as a distributor of pharmaceutical products. Its chief executive is Mika Seppanen. Its focus areas include Pharmaceutical Distributors and Diversified. Its competitors include AmerisourceBergen, Oriola, Wellgio Medical Oy, Tamro Finland and Verman.
Company details
CabApp, led by Mika Seppanen as CEO, specializes in providing healthcare solutions, pharmaceutical distributors, and diversified. Distributor of pharmaceutical products. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction. It continues to evolve, meeting industry challenges with strategic approaches.
Investors in CabApp
CabApp has secured backing from 1 investor. Prominent investors backing the company include MyXLine.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Delivers an app-based platform for cross-border courier services. | 2020 | myxline.fi | Mikkeli, Finland |
Investor details for CabApp
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CabApp
1 people are tracked at CabApp (1 in leadership).
| Name | Role | Group |
|---|---|---|
Mika Seppanen | CEO | Leadership |
Complete people profiles for CabApp
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CabApp
2 dated milestones of CabApp across 5 years, from founding to its latest funding, stage changes and deals.
- Founded CabApp is founded.
- Exit Acquired by MyXLine.
Competitors of CabApp
CabApp has 5 listed competitors in our database. They include AmerisourceBergen, Oriola, Wellgio Medical Oy, Tamro Finland and Verman, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| oriola.com | 1997 | Espoo, Finland | – | – | Pharmaceutical drugs and supplements are distributed by Oriola in Finland. | |
| wellgio.com | 2018 | Helsinki, Finland | – | 26 | Distributes pharmaceutical drugs to healthcare providers and clients efficiently. | |
| tamro.fi | 1895 | Vantaa, Finland | – | 187 | Provides distribution, logistics, and support for pharmaceuticals and health products. | |
| verman.fi | 1987 | Kerava, Finland | – | – | Residential apartments and flats are developed in various configurations. |
Detailed competitors of CabApp
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as CabApp (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CabApp
CabApp was founded in 2019.
CabApp is headquartered in Vantaa, Finland.
Mika Seppanen is the current CEO of CabApp.
CabApp, led by Mika Seppanen as CEO, specializes in providing healthcare solutions, pharmaceutical distributors, and diversified. Distributor of pharmaceutical products. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction. It continues to evolve, meeting industry challenges with strategic approaches.
CabApp's top competitors include AmerisourceBergen, Oriola and Verman.
CabApp has 1 investor. Key investors include MyXLine.
Yes. CabApp was acquired by MyXLine in February 2024.